Literature DB >> 2155515

Wing web or intravenous inoculation of chickens with v-src DNA induces visceral sarcomas.

M S Halpern1, D L Ewert, J M England.   

Abstract

We have previously found that sarcomas localized to visceral organs frequently arise following wing web inoculation of Rous sarcoma virus. This observation prompted an investigation of whether visceral sarcomas are also inducible by wing web inoculation of a subgenomic viral DNA fragment (v-src DNA) that includes v-src but lacks genes encoding viral structural protein. For this analysis, line SC chickens were inoculated with v-src DNA at 1-2 days posthatch and monitored for 9 weeks. Ninety percent of the chickens developed wing web (primary) tumors at the site of inoculation and, of these, about 30% exhibited visceral tumors. All tumors were histologically identifiable as sarcomas, and both the primary and visceral sarcoma cells were specifically reactive with two monoclonal antibodies elicited to different peptide fragments of pp60v-src. In a separate set of experiments, visceral sarcomas were also observed in about half of the line SC chickens that had been inoculated intravenously with v-src DNA. These results indicate that exogenous progeny virus production is not required for v-src-induced, visceral sarcoma formation. In addition, they demonstrate that intravenous inoculation of v-src DNA is a means to achieve rapid and widespread, disseminated sarcoma growth.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155515     DOI: 10.1016/0042-6822(90)90217-f

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  Tumor induction by the LTR, v-src, LTR DNA in four B (MHC) congenic lines of chickens.

Authors:  J Svoboda; J Plachý; J Hejnar; I Karakoz; R V Guntaka; J Geryk
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  src-specific immunity in inbred chickens bearing v-src DNA- and RSV-induced tumors.

Authors:  J Plachý; K Hála; J Hejnar; J Geryk; J Svoboda
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

3.  Tumor immunity generated in the course of regression of v-src-induced sarcomas.

Authors:  T W Wisner; J M England; D Y Pan; A W Stoker; M S Halpern
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

4.  Endogenous c-src as a determinant of the tumorigenicity of src oncogenes.

Authors:  M S Halpern; J M England; G C Kopen; A A Christou; R L Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

5.  Tumor cells induced by the v-src oncogene are heterogeneous for expression of markers of mesenchyme differentiation.

Authors:  J M England; M J Panella; G C Kopen; T W Wisner; M S Halpern
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

6.  One Group's Historical Reflections on DNA Vaccine Development.

Authors:  Ellen F Fynan; Shan Lu; Harriet L Robinson
Journal:  Hum Gene Ther       Date:  2018-08-21       Impact factor: 5.695

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.